Table 2.
CTR (n = 20) | RM–pre (n = 20) | SGP–pre (n = 20) | ANOVAs | ||||
---|---|---|---|---|---|---|---|
Main effect | Bonferroni post-hoc | ||||||
RM vs. CTR | SGP vs. CTR | RM vs. SGP | |||||
CAPS–TOT | 2.80 (6.41) | 77.80 (17.77) | 62.60 (23.99) | F(2, 47) = 83.995; p < 0.0001 | p < 0.0001 | p < 0.0001 | p = 0.092 |
CAPS–RE-EXP | 1.00 (2.85) | 17.90 (5.53) | 13.25 (9.34) | F(2, 47) = 27.360; p < 0.0001 | p < 0.0001 | p < 0.0001 | p = 0.234 |
CAPS–AVO-NUM | 0.65 (1.35) | 25.50 (7.32) | 17.90 (8.49) | F(2, 47) = 63.357; p < 0.0001 | p < 0.0001 | p < 0.0001 | p < 0.009 |
CAPS–H-AROU | 0.80 (1.74) | 15.30 (4.50) | 14.35 (5.63) | F(2, 47) = 64.579; p < 0.0001 | p < 0.0001 | p < 0.0001 | p = 1.000 |
CAPS–ASSOC | 0.00 (0.00) | 7.30 (4.03) | 8.00 (5.77) | F(2, 47) = 21.960; p < 0.0001 | p < 0.0001 | p < 0.0001 | p = 1.000 |
IES–TOT | 4.25 (7.41) | 41.65 (18.29) | 30.70 (18.39) | F(2, 57) = 30.483; p < 0.0001 | p < 0.0001 | p < 0.0001 | p = 0.091 |
IES–INT | 2.95 (6.44) | 20.50 (10.14) | 16.45 (10.70) | F(2, 57) = 19.578; p < 0.0001 | p < 0.0001 | p < 0.0001 | p = 0.520 |
IES–AVO | 1.30 (1.59) | 21.15 (9.25) | 14.25 (10.69) | F(2, 57) = 30.098; p < 0.0001 | p < 0.0001 | p < 0.0001 | p = 0.031 |
BDI–TOT | 2.10 (3.16) | 19.40 (10.02) | 13.45 (7.66) | F(2, 57) = 27.422; p < 0.0001 | p < 0.0001 | p < 0.0001 | p = 0.045 |
BDI–COG | 1.05 (1.79) | 12.50 (7.44) | 8.95 (5.07) | F(2, 57) = 24.462; p < 0.0001 | p < 0.0001 | p < 0.0001 | p = 0.116 |
BDI–SOM | 1.05 (1.67) | 6.90 (3.26) | 4.50 (2.97) | F(2, 57) = 23.374; p < 0.0001 | p < 0.0001 | p < 0.0001 | p = 0.022 |
SCL-90-R–GSI | 0.94 (0.50) | 1.31 (0.52) | 1.08 (0.05) | F(2, 57) = 3.888; p = 0.026 | p = 0.023 | p = 0.902 | p = 0.274 |
SCL-90-R–PST | 8.60 (8.83) | 58.15 (20.30) | 49.25 (25.44) | F(2, 57) = 36.817; p < 0.0001 | p < 0.0001 | p < 0.0001 | p = 0.461 |
SCL-90-R–PSDI | 0.89 (0.49) | 2.04 (0.51) | 1.63 (0.42) | F(2, 57) = 29.926; p < 0.0001 | p < 0.0001 | p < 0.0001 | p = 0.024 |
Post-hoc test with Bonferroni adjustment for multiple comparisons is also reported. Data are mean (SD). ET, EMDR Treatment; ET × G, EMDR Treatment × Group. CAPS scores for RM group are available for only 10 subjects.
CAPS, Clinician-Administered PTSD Scale; CAPS–TOT, CAPS total score; CAPS–RE-EXP, CAPS re-experiencing symptoms; CAPS–AVO-NUM, CAPS avoidant-numbing symptoms; CAPS–H-AROU, CAPS hyper-arousal symptoms; CAPS–ASSOC, CAPS associated features; IES, Impact of Event Scale; IES–TOT, IES total score; IES–INT, IES intrusion symptoms; IES–AVO, IES avoidance symptoms; BDI, Beck Depression Inventory; BDI–TOT, BDI total score; BDI–COG, BDI cognitive symptoms; BDI–SOM, BDI somatic symptoms; SCL-90-R, Symptom CheckList-90-Revised; SCL-90-R–GSI, SCL-90-R Global Severity Index; SCL-90-R–PST, SCL-90-R Positive Symptom Total; SCL-90-R–PSDI, SCL-90-R Positive Symptom Distress Index.